Dorsal Capital Management’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.4M Sell
1,300,000
-300,000
-19% -$12.6M 1.92% 19
2025
Q4
$82.7M Buy
1,600,000
+250,000
+19% +$15.3M 2.87% 15
2025
Q3
$100M Buy
1,350,000
+450,000
+50% +$33M 2.68% 17
2025
Q2
$68.8M Hold
900,000
1.83% 20
2025
Q1
$62.8M Buy
+900,000
New +$62.3M 1.92% 21
2019
Q1
Sell
-900,000
Closed -$37.4M 22
2018
Q4
$37.4M Buy
+900,000
New +$37.2M 2.62% 20

Other funds holding NTNX

Dorsal Capital Management's NTNX Position: Q1 2026 in Review

Dorsal Capital Management reduced its Nutanix (NTNX) stake by 19% in Q1 2026, selling an estimated $12.6M and leaving 1,300,000 shares worth $49.4M. The position accounts for 1.92% of the portfolio, ranked #19.

Dorsal Capital Management first reported a position in NTNX in Q4 2018 and has held it in 6 quarters since. The position peaked at $100M in Q3 2025. 533 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.

  • Dorsal Capital Management held 1,300,000 shares of Nutanix worth $49.4M as of Q1 2026.
  • Dorsal Capital Management sold 300,000 Nutanix shares in Q1 2026, an estimated $12.6M.
  • Nutanix made up 1.92% of Dorsal Capital Management's portfolio in Q1 2026, its #19 holding.
  • Dorsal Capital Management first reported a position in Nutanix in Q4 2018 and has held it in 6 quarters since.
  • Dorsal Capital Management's Nutanix position peaked at $100M in Q3 2025.
  • 533 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.

Based on Dorsal Capital Management's 13F filing for Q1 2026, filed 15 May 2026.